drugset / Trial / NCT06309966
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Timeline
- Start
- 2024-05-13
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BHV-7000 | Unknown | 50 mg | — |
| Subject | BHV-7000 | Unknown | 75 mg | — |